HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹5.64 | ₹6.36 | ₹13.02 | ₹10.80 | ₹6.85 |
What is the latest Earnings Per Share (EPS) of HIKAL ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹5.64 |
| Mar2024 | ₹6.36 |
| Mar2023 | ₹13.02 |
| Mar2022 | ₹10.80 |
| Mar2021 | ₹6.85 |
How is Earnings Per Share (EPS) of HIKAL Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.64 | -11.32 | |
| Mar2024 | ₹6.36 | -51.15 | |
| Mar2023 | ₹13.02 | 20.56 | |
| Mar2022 | ₹10.80 | 57.66 | |
| Mar2021 | ₹6.85 | - | |
Compare Earnings Per Share (EPS) of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,080.7 Cr | -0.2% | -18% | -56.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,470.0 Cr | -0.3% | 3.1% | 2.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,996.0 Cr | 0.5% | -2.9% | 5.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,440.0 Cr | 0.1% | 1.4% | 37.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,417.0 Cr | 1.9% | 1.4% | 10.7% | Stock Analytics | |
| CIPLA | ₹101,445.0 Cr | -3.3% | -6.9% | -17% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -0.2% |
-18% |
-56.8% |
| SENSEX | -0% |
-10.7% |
1% |
You may also like the below Video Courses